Cardiovascular Clinical Research

Discover the latest updates on cardiovascular clinical research, innovative studies, and exciting conference news. Join us on our journey as we explore the latest discoveries and innovations transforming how we understand and treat cardiovascular diseases.

  • All
  • Careers
  • Fairs
  • Insights

SCIRENT is excited to participate at the TCT Conference 2023 in San Francisco

SCIRENT is excited to participate at the TCT Conference from October 23-26, 2023, in San Francisco. The Transcatheter Cardiovascular Therapeutics (TCT) conference, hosted by the Cardiovascular Research Foundation (CRF), is the world's premier educational forum for interventional cardiovascular medicine. For...
heart surgery

First patient enrolled in feasibility trial for JuxtaFlow® Renal Assist Device (RAD)

Roswell, Georgia – 9 October, 2023 – Roivios Ltd., a medical device company pioneering a revolutionary treatment to reduce poor surgical outcomes associated with Acute Kidney Injury(AKI), today announces the first patient has been enrolled in the BIPASS-AKI early feasibilitystudy...
Come and be a part of Amsterdam ESC 2023, where you can witness groundbreaking developments in cardiovascular treatment. Collaborate with the most prominent professionals in the industry, delve into state-of-the-art abstracts, and unleash innovative possibilities for your patients. This is an unmissable chance to forge connections with Europe's leading cardiovascular CRO as well - let us work together towards achieving better health outcomes!

Join SCIRENT at ESC Congress 2023

SCIRENT will be participating in the renowned ESC Congress in Amsterdam from 25th to 28th August 2023. This prestigious event is a powerful platform for us as it brings together leading experts from the field of cardiology to shape the...
ESC Heart Failure 2023

Join Us in Prague for the ESC Heart Failure Meeting

Save the dates in your agenda and join us in Prague from 20 to 23 May 2023 for the ESC Heart Failure Association (HFA) annual meeting bringing together scientists, healthcare professionals, and other players from around the world. The world's leading...
CSI Frankfurt 2023 is one of the world's leading clinical research organizations, dedicated to advancing new treatments for cardiovascular diseases. We need your help to make this trial a success. Read our blog to learn more about the trial and how you can be part of it. Join us in our mission to save lives and make a difference!

Conferences in Cardiovascular Clinical Research 2023

SCIRENT is thrilled to announce that we will be attending several high-ranking cardiovascular conferences in 2023.  Meet our team to discover how SCIRENT, a specialized cardiovascular research organization, can help your business develop innovative therapies. Our competence in clinical research...

Connect with Us at HFSA Annual Scientific Meeting 2022

SCIRENT, a full-service contract research organization (CRO) specializing in cardiovascular trials, is joining forces with CCS, a US-based cardiovascular clinical research organization, at HFSA Annual Scientific Meeting 2022 in Washington. Come and meet us at booth 228 from September 30, 2022 -...

Meet Us at ESC Congress 2022 in Barcelona

SCIRENT is excited to participate at the ESC Congress 2022 in Barcelona, which is taking place from 26-29 August 2022. Please book an appointment with our leadership to learn more about our industry-leading cardiovascular research services and patient recruitment capabilities....
SCIRENT is exhibitor at the American Heart Association 2021 Scientific Sessions.

Meet Us at AHA 2021

10.11.2021. SCIRENT is attending the American Heart Association’s Scientific Sessions, AHA 2021, from November 13-15, 2021 as a proud exhibitor. Visit our booth and connect with us live to learn more about our industry-leading cardiovascular research services, patient recruitment capabilities,...

SCIRENT Appoints Dr. Maximilian Posch, MD, as Chief Medical Officer

BERLIN, Sept. 21, 2021 /PRNewswire/ -- SCIRENT, an international full-service cardiovascular contract research organization (CRO), is proud to appoint Dr. Maximilian Posch as Chief Medical Officer. In his new position, Dr. Posch will be an important driver of SCIRENT's growth...
Berlin Heals' innovative implantable C-MIC device delivers encouraging clinical results in the treatment of heart failure.

Innovative Medical Device for Heart Failure Treatment Delivers Promising Results

Berlin Heals' innovative implantable C-MIC device has demonstrated encouraging clinical results in the treatment of heart failure. They are now published in ESC Heart Failure. The C-MIC is a small implantable device that delivers a minimal constant electrical microcurrent to...
Crisis Management for Rapid Resumption of Cardiovascular Clinical Trials during the COVID-19 pandemic

Restarting by Design: Agile Crisis Management for Rapid Resumption of Cardiovascular Clinical Trials

The entire landscape of hospital-based clinical trials dramatically changed when COVID-19 singlehandedly stopped the global recruitment of ongoing cardiovascular trials. Heart failure clinical trials were already subject to factors such as regional variation in clinical practice, trial implementation, and patient...
SCIRENT Virtual Core Lab

SCIRENT and Virtonomy Announce Joint Efforts to Advance Use of Virtual Patients in Medical Device Clinical Trials

SCIRENT, a full-service contract research organization (CRO) specialized in cardiovascular trials, and Virtonomy, a pioneer in developing data-driven clinical trials using virtual patients, announced today their cooperation on the use of virtual patients in medical device clinical trials. Both companies offer...
Human Heart Illustration

An Innovative Approach in Treating Heart Failure

Global medical technology and innovation company, LivaNova PLC, conducts the large medical device study ANTHEM-HFrEF to evaluate whether autonomic regulation therapy will benefit patients with symptomatic heart failure and reduced ejection fraction. The trial is performed by the US-based CRO...

SCIRENT Supports Phase IIa Study of BC 007 for the Treatment of Heart Failure

Heart failure is one of the most common causes of death in Western society and is becoming increasingly global. Its socio-economic impact is enormous, equivalent to the impact caused by cancer. Although there has been progress in treatment over the...

COVID-19: Keeping up Trial Safety and Progress

The global COVID-19 pandemic has largely impacted the healthcare system and also the conduct of clinical trials. Many sponsors have had to adapt clinical trial operations to the changing conditions of the pandemic, causing major disruptions in trial conduct. Some...

Thank you for your application.

We will get in touch shortly.

Thank you. Your data was submitted successfully.

We will get in touch shortly.